SCHEMBL1283733

SCHEMBL1283733

CC(C)(C)C(O)(CCCOc1ccc(Cl)cc1)Cn1ncnc1S

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.41
ALDH1A1 P00352 4/20 0.40
CYP3A4 P08684 1/20 0.40
FDPS P14324 2/20 0.37
KCNH2 Q12809 2/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
HPGD P15428 3/20 0.33
KMT2A Q03164 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MEN1 O00255 2/20 0.33
HTT P42858 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1282118 0.96 ALDH1A1 (0.40) PPARAALDH1A1CYP3A4FDPSKCNH2
SCHEMBL1282173 0.95 ALDH1A1 (0.39) PPARAALDH1A1CYP3A4FDPS
SCHEMBL1282957 0.89 FDPS (0.37) ALDH1A1FDPSSMN1; SMN2DRD2DRD4
SCHEMBL1281724 0.89 PPARA (0.40) PPARAALDH1A1FDPS
SCHEMBL1281732 0.88 KDM4E (0.39) KCNH2SMN1; SMN2DRD2DRD4KMT2A
SCHEMBL1281900 0.86 USP2 (0.36) PPARAALDH1A1FDPSSMN1; SMN2DRD2
SCHEMBL1281563 0.86 PPARA (0.36) PPARAALDH1A1KCNH2RAB9ASMN1; SMN2
SCHEMBL1282635 0.86 KCNA3 (0.38) PPARAFDPS
SCHEMBL1282197 0.85 HPGD (0.41) ALDH1A1CYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL1282110 0.85 HTT (0.36) ALDH1A1FDPSSMN1; SMN2DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443098-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2012-04-25 EP disclosed
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives BASF SE (DE) 2012-04-12 US disclosed
WO-2010146112-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives ERG28, CYP51A1, DPM1 PPARA 4422/4885ALDH1A1 1943/4885CYP3A4 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.